Rituximab vs Vancomycin

## Rituximab vs Vancomycin: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Vancomycin**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

**Vancomycin**: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Vancomycin — 4-6 hours.

## Chemical Properties

**Molecular Formula**: Rituximab — N/A; Vancomycin — C66H75Cl2N9O24.

**Molecular Weight**: Rituximab — N/A; Vancomycin — 1449.2500 g/mol.

**Type**: Rituximab — Antibody; Vancomycin — Small molecule.